Light at the End of the Tunnel for ASPS Patients
Immunotherapy has helped some young people with alveolar soft part sarcoma (ASPS), a rare cancer, but there’s more work to be done.
Home > Practical Knowledge > Light at the End of the Tunnel for ASPS Patients
Immunotherapy has helped some young people with alveolar soft part sarcoma (ASPS), a rare cancer, but there’s more work to be done.
In every issue, Cancer Today offers information and inspiration as readers face the challenges of diagnosis, treatment, survivorship, or caregiving. Cancer Today subscriptions are free to cancer patients, survivors, caregivers, and others in the United States.
Subscribe TodayYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now